U.S. FDA panel recommends approval of NPS hormone replacement drug

[riky]

U.S. FDA panel recommends approval of NPS hormone replacement drug

Food and Drug Administration on Friday voted 8-5 to recommend approval for Natpara, a hormone replacement therapy developed by NPS Pharmaceuticals Inc. Shares of NPS, which were halted in regular trading, were down about 1 percent at $32.40 after hours. Since an FDA staff report to the panel was released last week, the shares have gained about 20 percent. Natpara is designed to treat hypoparathyroidism, a condition in which the body's parathyroid gland does not secrete enough parathyroid hormone (PTH). The hormone works with vitamin D to regulate body calcium.

Source: You are not allowed to view links. Register or Login